Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor receptor substrate 3 (FRS3) is an adapter protein localized to the peripheral plasma membrane that serves as a critical link in transducing signals from activated fibroblast growth factor receptors (FGFRs) to intracellular effectors, particularly the MAPK (Mitogen-Activated Protein Kinase) and PI3K/AKT pathways[1][3][6]. Upon FGFR stimulation, FRS3 becomes tyrosine phosphorylated, subsequently recruiting downstream signaling components such as GRB2 and Gab1, and modulating diverse cellular functions including differentiation and proliferation[1][3]. FRS3 is especially important in mediating FGFR1 function during neuronal development and can also participate in signaling from neurotrophin receptors such as NTRK1-3[3]. While it shares structural and functional similarity with FRS2, FRS3 has distinct, context-dependent roles, particularly in the negative regulation of ERK2 activity and in certain cancer types including thyroid and prostate cancer[3][6]. Defects or dysregulation in FRS3-mediated signaling have been implicated in cancer pathogenesis and developmental disorders such as Kallmann syndrome and multiple endocrine neoplasia[1][2][6]. Notes: - FRS3 is considered an adaptor/scaffold protein, not a receptor or enzyme itself; thus, it does not have known drug ligands or approved therapies targeting it directly as of current knowledge[3][6]. - There are closely related paralogs such as FRS2 (also known as SNT-1 or FRS2-alpha)[1][3]. - Contextual data (e.g., kidney, neuronal, or endocrine development) suggest roles in highly regulated developmental pathways and malignancy[1][3][6].
Adapter or scaffold for FGFR, transmitting signals to MAPK/ERK and PI3K/AKT pathways; required for FGFR1-mediated signaling; mediates signal transduction from select neurotrophin receptors (e.g., NTRK1, NTRK2, NTRK3)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor receptor substrate 3 (FRS3).